Trial Profile
Planned pivotal phase III trial of danazol in patients with diabetic macular oedema
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 03 Dec 2012
Price :
$35
*
At a glance
- Drugs Danazol (Primary)
- Indications Diabetic macular oedema
- Focus Registrational; Therapeutic Use
- 03 Dec 2012 New trial record
- 14 Nov 2012 Sites in Europe have been identified for this trial, according to an Ampio Pharmaceuticals media release.